Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
In your 20s, it's crucial to know what financial mistakes to avoid. Discover key insights to help you manage your money wisely.
26,712 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Apple quietly hiking prices on Mac and iPad models signals a shift in pricing strategy as memory costs rise, with inv...
FNDF, the ETF tracking developed markets outside the U.S., pays semi-annual dividends funded by foreign cash flow. To...
Carlisle Companies is pursuing Owens Corning with an unsolicited offer, aiming to transform into a larger, more diver...
A free cash flow ETF is delivering a surprising edge in 2026, outperforming the S&P 500 as investors rotate toward ca...
A three-week ban on Anthropic's AI services by U.S. regulators ended, igniting a debate over whether the episode coul...
Christina Qi, once at the helm of a high-speed trading firm, has launched Databento into the market data arena. The s...
A federal case in Western Missouri pits 15 borrowers against Veterans United over alleged kickbacks and steering tied...
A Goldman Sachs economist offers reality on AI adoption timing, arguing that productivity gains from AI are likely to...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...
A value-driven, catalyst-led small-cap approach is drawing attention as investors seek mispriced names with clear ups...
Founders Fund has fully exited ETHZilla, and Peter Thiel has followed with a complete stake unload, underscoring a br...